Skip to main content
. 2017 Jun 14;7:3493. doi: 10.1038/s41598-017-03728-3

Figure 6.

Figure 6

RAD001 decreases tumour vasculature in mouse model of human prostate cancer. Subcutaneous PC3 tumours were established in nude mice as described in materials and methods and allowed to grow for two weeks. Mice were treated with sham (Cont), 5 mg/kg RAD001 (RAD), 5 mg/kg docetaxel (Doc) and combination of these drugs (RAD + Doc) for three weeks. (A) Representative images of subcutaneous human tumours in mice after corresponding treatments. (B) Tumour volumes at week five. (C) P70S6K phosphorylation in tumours was measured using ELISA. (D–F) Human SK1 (D), VEGF (E) and mouse CD31 (F) expression was determined by qRT-PCR. Columns, mean values of n = 8; bars, SEM. (*P < 0.05; **P < 0.01; §P < 0.001; ns, not significant, P > 0.05).